John Markin Joins EnviroLogix as President and Chief Executive Officer

Portland, Maine, - EnviroLogix Inc., a leading provider of test kits for the food and feed safety, water quality, and transgenic trait detection markets, today announced that they have successfully completed their search for a new President and CEO following the retirement of its founder and former President, Bruce S. Ferguson. John N. Markin, formerly [...]

FDA Clears Life Technologies’ OpTmizer™ T-Cell Growth Medium for Use in Clinical Trials

CARLSBAD, Calif., -- Life Technologies Corporation (NASDAQ: LIFE) today announced it has received FDA 510(k) clearance for its OpTmizer™ CTS™ T-Cell Expansion Tissue Culture Medium — a reagent that is now cleared as a Class II medical device and offers cost- and time-saving advantages for transitioning studies from the research bench to clinical trials. The [...]

New Molecular Assay Detects Rapidly Emerging Multidrug-Resistant Superbug

Baltimore, MD – BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced the release of a research use only (RUO) molecular test designed to rapidly detect antibiotic resistance genes found in the superbug known as carbapenem-resistant Enterobacteriaceae (CRE). These deadly organisms are associated with high mortality rates, are easily spread [...]

IonSense, Inc. Issued Two Patents on Direct Analysis in Real Time Mass Spectrometry. Introduces New Product at International Mass Spectrometry Conference, Kyoto, Japan.

Saugus, MA, -- IonSense, Inc. is pleased to announce that the U.S. Patent and Trademark Office (USPTO) has issued two patents supporting its Direct Analysis in Real Time (or DART®) mass spectrometry products. The company’s DART ion sources and application accessories enable the fast, simple analysis of materials in food safety, drug development, forensics, environmental, [...]

NanoString Technologies Obtains CE Mark for PAM50-based Test for Breast Cancer

SEATTLE, Wash – NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced it has obtained the CE Mark for its PAM50-based gene expression test for breast cancer, clearing the company to sell its test in the European Union and other countries recognizing the [...]

Centice Announces Development of Low-Cost Deep UV Raman Spectrometer

MORRISVILLE, N.C.-- Centice Corporation, a pioneer in chemical verification and identification using Raman spectroscopy and computational sensor technology, today announced the development of a new low-cost deep ultraviolet (UV) coded aperture Raman spectrometer. The current version enables trace analysis of surface chemicals and contaminants. It will be showcased at SCIentific eXchange (SciX), the annual meeting [...]

Agilent Technologies Licenses SureFISH to BioDiscovery

Agilent Technologies Inc. (NYSE: A) today announced that it has entered into a licensing agreement with BioDiscovery, Inc., enabling BioDiscovery customers to access Agilent SureFISH probes directly from BioDiscovery's Nexus software. Researchers using a variety of cytogenetic microarray platforms can now quickly identify aberrations via Nexus and immediately identify/link to available oligonucleotide-based fluorescent in situ [...]

5AM Solutions Plays Key Role in the Development of Just Released Virtual Repository for Dried Blood Spots (VRDBS)

The Newborn Screening Translational Research Network (NBSTRN) Coordinating Center recently announced the release of the Virtual Repository of Dried Blood Spots (VRDBS), an open source biospecimen management system. The VRDBS is a research tool allowing investigators more efficient access to dried blood spot (DBS) specimens. The NBSTRN Coordinating Center is funded by a contract to [...]

Knome Introduces the knoSYS™100

CAMBRIDGE, MA – – Knome Inc. announced today that it is taking orders for the knoSYS™100, the first plug-and-play, fully integrated hardware and software system designed to help researchers in medical and academic institutions interpret human whole genomes. The knoSYS™100 was developed to help geneticists discover relevant genetic variation, investigate diseases of unknown cause, and [...]

Phenomenex and ChromaDex® to Collaborate on Reference Standards Solutions for Dietary Supplements

Torrance, CA and Irvine, CA - Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, and ChromaDex® Corporation (OTCBB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today [...]

Access IBO on Knowledge Center